Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,614.50
Bid: 1,614.50
Ask: 1,615.00
Change: -152.00 (-8.60%)
Spread: 0.50 (0.031%)
Open: 1,616.50
High: 1,621.00
Low: 1,589.50
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: Goldman Cuts RBS To Neutral From Buy

Tue, 12th Nov 2013 10:18

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:
----------
FTSE 100
----------
NOMURA DOWNGRADES BRITISH SKY BROADCASTING GROUP PLC (BSY.L) TO REDUCE FROM BUY
----------
S&P CAPITAL IQ CUTS BSKYB TO 'SELL' ('BUY') - PRICE TARGET 700 (1050) PENCE
----------
CREDIT SUISSE CUTS BSKYB TO 'UNDERPERFORM' ('NEUTRAL') - PRICE TARGET 700 (810) PENCE
----------
UBS RAISES SMITHS GROUP PRICE TARGET TO 1000 (750) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RBS TO 'NEUTRAL' ('BUY') - TARGET 370 (400) PENCE
----------
NOMURA RAISES RBS PRICE TARGET TO 285 (270) PENCE - 'REDUCE'
----------
MACQUARIE REMOVES RBS FROM 'CONVICTION SELL LIST'
----------
JPMORGAN CUTS RSA INSURANCE TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 126 (140) P.
----------
NOMURA CUTS RSA INSURANCE PRICE TARGET TO 113 (120) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ITV TO 'NEUTRAL' ('BUY') - TARGET 191 (180) PENCE
----------
PANMURE CUTS GLAXOSMITHKLINE TO 'HOLD' ('BUY') - TARGET 1,750 (1,850) PENCE
----------
SOCGEN RAISES SHIRE PRICE TARGET TO 3615 (3270) PENCE - 'BUY'
----------
MACQUARIE REMOVES IAG FROM 'CONVICTION BUY LIST' - 'OUTPERFORM'
----------
MORGAN STANLEY RAISES ROLLS-ROYCE PRICE TARGET TO 1400 (1300) P. - 'OVERWEIGHT'
----------
FTSE 250
----------
UBS CUTS BALFOUR BEATTY TO 'SELL' ('NEUTRAL') - TARGET 245 (220) PENCE
----------
UBS CUTS COBHAM PRICE TARGET TO 290 (305) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS COBHAM PRICE TARGET TO 270 (275) PENCE - 'HOLD'
----------
BARCLAYS INITIATES F&C ASSET MANAGEMENT WITH 'UNDERWEIGHT' - TARGET 90 PENCE
----------
CITIGROUP RAISES LONMIN PRICE TARGET TO 453 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LONMIN PRICE TARGET TO 390 (315) PENCE - 'HOLD'
----------
JPMORGAN RAISES LONMIN PRICE TARGET TO 430 (400) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LONMIN PRICE TARGET TO 512 (485) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES HALFORDS GROUP PRICE TARGET TO 410 (330) PENCE - 'SELL'
----------
DEUTSCHE BANK RAISES WH SMITH PLC PRICE TARGET TO 1075 (960) PENCE - 'BUY'
----------
EXANE BNP RAISES SHAFTESBURY TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 580 PENCE
----------
NUMIS CUTS MENZIES(JOHN) TO 'HOLD' ('ADD') - TARGET 774 (834) PENCE
----------
PANMURE RAISES BTG PRICE TARGET TO 490 (450) PENCE - 'BUY'
----------
PANMURE RAISES RIGHTMOVE PRICE TARGET TO 3,130 (3,000) PENCE - 'BUY'
----------
CANACCORD RAISES CATLIN GROUP PRICE TARGET TO 550 (540) PENCE - 'BUY'
----------
NUMIS RAISES CATLIN GROUP TO 'HOLD' ('REDUCE') - TARGET 575 (420) PENCE
----------
JEFFERIES CUTS MORGAN ADVANCED MATERIALS PRICE TARGET TO 340 (345) PENCE- 'BUY'
----------
JEFFERIES RAISES RENTOKIL INITIAL PRICE TARGET TO 116 (104) PENCE - 'HOLD'
----------
NUMIS CUTS DIGNITY TO 'HOLD' ('ADD') - TARGET 1,575 (1,625) PENCE
----------
Numis Upgrades Oxford Instruments To Buy From Add, Price Target 1,600p
----------
ALL-SHARE AND AIM
----------
GOLDMAN RAISES SHANKS GROUP PRICE TARGET TO 128 (126) PENCE - 'BUY'
----------
CANACCORD CUTS CHESNARA PLC TO 'HOLD' ('BUY') - TARGET 300 (290) PENCE
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.